search icon
  • Print
  • ShareThis
  • Text Size


In order to contribute to the discussion forum you need to be an IDSA member. If you are an IDSA member, please login now. Please read our Discussion Forum Guidelines and Terms of Use before joining.

Hepatitis C

Welcome to Hepatitis C Management Discussion Board! The Hepatitis C Management Discussion Board provides Infectious Disease Clinicians a platform to connect with colleagues to exchange information, case studies, complications, and new developments on matters concerning hepatitis C treatment and management. Certain case studies will be developed into clinical vignettes and will be available to Infectious Disease Clinicians for future reference. Please be respectful of all participants and their respective comments. Please read our Terms of Use and Discussion Forum Guidelines.

 

Any diagnostic or therapeutic recommendations and all opinions presented are those of the individual contributor. They do not necessarily represent the views of IDSA. The reader assumes all risks in using this information. The IDSA Hepatitis C Discussion Forum is in full compliance with HIPPA. IDSA bears no responsibility for the accuracy of participant comments and will bear no legal liability for discussion results.

If a participant wishes to post an issue on the IDSA Hepatitis C Discussion Forum, the participant is strongly urged to provide contact information for possible offline discussion via phone or email concerning the posted issue.


RSS Feed Search Category View 
Drug Therapy
  Topics Topic Starter Replies Views Last Post
AbbVie Submits FDA Application for All Oral HCV Therapy tkim@idsociety.org 0 8620 Tuesday, April 22, 2014 1:52 PM 
Bristol-Myers Squibb Files for FDA Approval of NS5A Drug Combination tkim@idsociety.org 0 8540 Thursday, April 10, 2014 1:50 PM 
Merck Unveils Interim Phase II Results tkim@idsociety.org 0 8549 Thursday, April 10, 2014 1:46 PM 
Spurred by pricey Gilead hep C drug, payers cook up new cost-control moves tkim@idsociety.org 0 9316 Monday, January 27, 2014 1:44 PM 
Phase III Results for Gilead Hep C Combo tkim@idsociety.org 0 9434 Wednesday, December 18, 2013 12:51 PM 
Key hep C protein revealed, paving the way for new vaccines tkim@idsociety.org 0 9506 Wednesday, December 4, 2013 7:57 AM 
AbbVie steps closer to FDA filing as first hep C PhIII delivers promising results tkim@idsociety.org 0 9567 Monday, November 18, 2013 1:45 PM 
FDA Approved Changes to Incivek (telaprevir) Product Labeling to Include OPTIMIZE Trial Results tkim@idsociety.org 0 9877 Wednesday, October 30, 2013 7:56 AM 
Gilead's Sofosbuvir Gains FDA Panel Approval tkim@idsociety.org 0 9939 Monday, October 28, 2013 1:14 PM 
FDA Internal Review of Sofosbuvir tkim@idsociety.org 0 9935 Wednesday, October 23, 2013 1:21 PM 
Clinicians Wait for Next Wave of Hepatitis C Antivirals - By: Debra Gordon tkim@idsociety.org 0 11930 Tuesday, June 11, 2013 3:43 PM 
Bristol-Myers gains FDA breakthrough track for HCV drug approval tkim@idsociety.org 0 12758 Thursday, April 25, 2013 2:00 PM 
Gilead Successfully Completes Fourth Phase III Study tkim 0 12836 Tuesday, February 19, 2013 1:03 PM 
Gilead gains FDA approval for hep C combo pill ThomasKim 0 4027 Monday, October 13, 2014 12:34 PM 
AbbVie Announces Positive Phase III Results ThomasKim 0 8463 Friday, April 11, 2014 1:52 PM 
Gilead Next Generation Combination Pill ThomasKim 0 8756 Monday, March 24, 2014 1:01 PM 
Gilead says payers feel comfortable with the cost of Sovaldi ThomasKim 0 9154 Friday, February 14, 2014 1:06 PM 
FDA approves Sovaldi for chronic hepatitis C ThomasKim 0 9510 Monday, December 9, 2013 10:21 AM 
Indication and Usage of Olysio (simeprevir) for the Treatment of Chronic Hepatitis C ThomasKim 0 9471 Monday, November 25, 2013 2:38 PM 
J&J, Medivir gain FDA OK for new hep C therapy simeprevir ThomasKim 0 9498 Monday, November 25, 2013 1:08 PM 
J&J wins FDA panel blessing for hep C blockbuster hopeful ThomasKim 0 9757 Friday, October 25, 2013 2:32 PM 
Simeprevir Earns Positive Internal Review from FDA ThomasKim 0 9909 Tuesday, October 22, 2013 1:33 PM 
More Drugs Show Promise in Fighting Hepatitis C - HealthDay Article ThomasKim 0 10474 Thursday, August 15, 2013 11:36 AM 
Gilead applies for FDA approval for Sofosbuvir ThomasKim 0 12785 Tuesday, April 9, 2013 1:36 PM 
J&J, Gilead combo drug therapy clears hep C in 100% of Phase IIa cohort ThomasKim 0 13191 Monday, March 4, 2013 1:00 PM 
Gilead Passes Two Phase III Test with HCV Pill ThomasKim 0 13019 Monday, February 4, 2013 4:01 PM 
 

| HIVMA | Contact Us

© Copyright IDSA 2015 Infectious Diseases Society of America

Full Site Mobile Site